Advertisement

How Can We Identify the Presence of Metastases?

  • Brunella Barbaro
Chapter

Abstract

Rectal cancer most commonly metastasizes to the liver, developing hepatic metastases either synchronously or metachronously. The lung is the second most common organ to harbor rectal cancer metastases. Brain and bone metastases are uncommon. Imaging plays an important role in the workup of patients with mRC by helping enumerate the number and sites of metastases, determine resectability, assess response to systemic and liver-directed therapies, and detect disease recurrences. Concurrent with advances in the treatment of rectal cancer, there have been major advances in radiology, with the development of new imaging modalities, functional imaging techniques, and contrast media.

References

  1. 1.
    Tirumani SH, Kim KW, Nishino M et al (2014) Update on the role of imaging in management of metastatic colorectal cancer. Radiographics 34:1908–1928CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kim HJ, Lee SS, Byun JH et al (2015) Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology 274(3):712–722CrossRefPubMedGoogle Scholar
  3. 3.
    Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM (2012) Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol 85(1015):980–989CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    van Kessel CS, Buckens CFM, Bosch MAAJ, Leeuwen MS, Hillegers-berg R, Verkooijen HM (2012) Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 19(9):2805–2813CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Brush J, Boyd K, Chappell F et al (2011) The value of FDG positron emission tomography/computerized tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess 15:1–192CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    NCCN Clinical practice guidelines in oncology colon cancer version 3.2013. National Comprehensive Cancer Network web site. http://www.nccn.org/profes sionals/physician_gls/pdf/colon.pdf. Published 26 Nov 2012. Accessed 12 Mar 2013
  7. 7.
    Barbaro B, Caputo F, Tebala C et al (2009) Preoperative right portal vein embolisation: indications and results. Radiol Med 114:553–570CrossRefPubMedGoogle Scholar
  8. 8.
    Barbaro B, Di Stasi C, Nuzzo G et al (2003) Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 44:98–102PubMedGoogle Scholar
  9. 9.
    Jung EJ, Kim SR, Ryu CG, Paik JH, Yi JG, Hwang DY (2015) Indeterminate pulmonary nodules in colorectal cancer. World J Gastroenterol 21(10):2967–2972CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Bamba Y, Itabashi M, Kameoka S (2011) Value of PET/CT imaging for diagnosing pulmonary metastasis of colorectal cancer. Hepato-Gastroenterology 58:1972–1974PubMedGoogle Scholar
  11. 11.
    Sanli Y, Kuyumcu S, Ozkan ZG et al (2012) The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels. Ann Nucl Med 26:551–558CrossRefPubMedGoogle Scholar
  12. 12.
    Adam R, De Gramont A, Figueras J (2012) The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 17(10):1225–1239CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Valentini V, Glimelius B, Haustermans K et al (2014) EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist’s expert review. Radiother Oncol 110(1):195–198CrossRefPubMedGoogle Scholar
  14. 14.
    Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN (2013) Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB 15(2):91–103CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Catalano OA, Rosen BR, Sahani DV et al (2013) Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients – a hypothesis-generating exploratory study. Radiology 269(3):857–869CrossRefPubMedGoogle Scholar
  16. 16.
    Beiderwellen K, Gomez B, Buchbender C et al (2013) Depiction and characterization of liver lesions in whole body [(18)F]-FDG PET/MRI. Eur J Radiol 82(11):e669–e675CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2018

Authors and Affiliations

  1. 1.Institute of RadiologySchool of Medicine, Catholic University – “Fondazione Policlinico Universitario A. Gemelli”RomeItaly

Personalised recommendations